Prudential Financial Inc. Lowers Position in USANA Health Sciences, Inc. (NYSE:USNA)

Prudential Financial Inc. lessened its stake in USANA Health Sciences, Inc. (NYSE:USNA – Free Report) by 5.

1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,210 shares of the company’s stock after selling 600 shares during the quarter. Prudential Financial Inc.



owned approximately 0.06% of USANA Health Sciences worth $402,000 at the end of the most recent reporting period. Several other hedge funds also recently modified their holdings of USNA.

R Squared Ltd purchased a new position in USANA Health Sciences during the 4th quarter worth $28,000. Exchange Traded Concepts LLC boosted its holdings in USANA Health Sciences by 11.3% during the fourth quarter.

Exchange Traded Concepts LLC now owns 8,578 shares of the company’s stock worth $308,000 after purchasing an additional 869 shares during the last quarter. Principal Financial Group Inc. grew its position in USANA Health Sciences by 2.

8% in the 4th quarter. Principal Financial Group Inc. now owns 53,603 shares of the company’s stock worth $1,924,000 after purchasing an additional 1,480 shares in the last quarter.

Franklin Resources Inc. increased its stake in USANA Health Sciences by 9.2% in the 3rd quarter.

Franklin Resources Inc. now owns 21,050 shares of the company’s stock valued at $750,000 after buying an additional 1,771 shares during the last quarter. Finally, Amundi boosted its stake in shares of USANA Health Sciences by 85.

3% in the 4th quarter. Amundi now owns 4,872 shares of the company’s stock worth $170,000 after buying an additional 2,243 shares during the last quarter. Hedge funds and other institutional investors own 54.

25% of the company’s stock. USANA Health Sciences Stock Up 4.3 %Shares of USNA stock opened at $25.

25 on Thursday. USANA Health Sciences, Inc. has a 12-month low of $23.

67 and a 12-month high of $49.78. The company has a 50 day moving average of $29.

43 and a 200-day moving average of $34.19. The firm has a market cap of $477.

35 million, a P/E ratio of 8.92, a PEG ratio of 0.93 and a beta of 1.

00. USANA Health Sciences (NYSE:USNA – Get Free Report) last issued its earnings results on Tuesday, February 25th. The company reported $0.

64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.15.

The firm had revenue of $213.61 million for the quarter, compared to analyst estimates of $208.82 million.

USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%.

As a group, equities analysts expect that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Insiders Place Their BetsIn related news, insider David Mulham Mulham sold 3,234 shares of the company’s stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $32.98, for a total transaction of $106,657.

32. Following the sale, the insider now owns 12,775 shares of the company’s stock, valued at approximately $421,319.50.

This represents a 20.20 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Also, insider Joshua Foukas sold 5,732 shares of the firm’s stock in a transaction on Wednesday, March 12th. The shares were sold at an average price of $32.54, for a total transaction of $186,519.

28. The disclosure for this sale can be found here. Insiders have sold a total of 15,920 shares of company stock worth $500,285 over the last 90 days.

Corporate insiders own 0.33% of the company’s stock. Analyst Upgrades and DowngradesA number of analysts recently commented on the company.

StockNews.com downgraded USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. DA Davidson lowered their target price on USANA Health Sciences from $38.

00 to $36.00 and set a “neutral” rating on the stock in a research note on Thursday, February 27th. Finally, Sidoti downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 18th.

View Our Latest Analysis on USNAUSANA Health Sciences Profile (Free Report)USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.Further ReadingFive stocks we like better than USANA Health SciencesHow to Use the MarketBeat Stock Screener Quantum Computing: The $6.

5 Billion Opportunity You Can’t IgnoreWhat Are Treasury Bonds?Are Tariffs Threatening Disney’s Comeback Story?What is the Australian Securities Exchange (ASX) Is Alphabet a Generational Buying Opportunity at These Levels?Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA – Free Report).

.